Riskpilot← Back to searchSign inGet full accessA+ Science AB
ABIn liquidationOrg 5566526835Research and experimental development on natural sciences and engineering · NACE 7210Est. 20030 employees
Revenue 2023
SEK 14,1M
-11% vs 2022
EBITDA margin
4.8%
+818% vs 2022
Equity ratio
15.3%
Financial strength
Net profit 2023
SEK 469K
+437% vs 2022
| Revenue | SEK 14,1M | -11% |
| EBITDA | SEK 682K | +818% |
| Net profit | SEK 469K | +437% |
| Total assets | SEK 8,1M | +19% |
| Equity | SEK 1,2M | +60% |
| Employees | 0 | — |
Legal name
A+ Science AB
Org number
5566526835
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11 december 2003
Share capital
SEK 520 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget har till föremål för sin verksamhet att tillhandahålla tjänster inom klinsk forskning.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 17 748 | 26 901 | 18 101 | 15 340 | 15 864 | 14 130 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | 376 | 148 | −1 689 | −2 355 | 261 | 3 | −1 212 | −95 | 682 |
| Depreciation & amort. | −95 | −89 | −104 | −30 | −20 | −15 | −1 | −40 | −240 |
| EBIT | 281 | 59 | −1 793 | −2 385 | 241 | −12 | −1 213 | −135 | 442 |
| Net financials | 15 | 2 | −1 | 68 | −2 | — | −3 | −4 | 27 |
| Profit before tax | 296 | 61 | −1 793 | −2 317 | 239 | −12 | −1 216 | −139 | 469 |
| Tax | −0 | 330 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 296 | 391 | −1 793 | −2 317 | 239 | −12 | −1 216 | −139 | 469 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 14 192 | 16 327 | 13 736 | 8 422 | 11 166 | 4 729 | 4 442 | 6 836 | 8 135 |
| Equity | 5 626 | 6 017 | 4 225 | 1 907 | 2 146 | 2 134 | 918 | 779 | 1 248 |
| Long-term debt | 0 | 132 | 125 | 125 | 125 | 125 | 125 | 125 | 0 |
| Short-term debt | 8 566 | 10 178 | 9 386 | 6 390 | 8 895 | 2 470 | 3 399 | 5 932 | 6 887 |
| Total debt | 8 566 | 10 310 | 9 511 | 6 515 | 9 020 | 2 595 | 3 524 | 6 057 | 6 887 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20152023
Equity ratio
15.3%
This company
38.2%
Market median
-60% vs market
20152023
Return on equity
37.6%
This company
18.4%
Market median
+104% vs market
20152023
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20152023
Asset turnover
1.74×
This company
1.12×
Market median
+55% vs market
20152023
Debt / equity
5.52×
This company
0.62×
Market median
-790% vs market
20152023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PH Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
IM Chief Auditor | Chief Auditor | 2020 | — | — |
MV Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
MJ Chief Auditor | Chief Auditor | 2022 | — | — |
JF Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
EK Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
MK Liquidator | Liquidator | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of A+ Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Håkan Fröderberg | Chief Executive Officer | 0 companies |
| Inger Margareta Sjöberg | Chief Auditor | 0 companies |
| Martin Viktor Tiberg | Chief Executive Officer | 0 companies |
| Mikael Johan Jonsson | Chief Auditor | 0 companies |
| Jennifer Felicity Heyno | Chief Executive Officer | 0 companies |
| Eva Katarina Fredriksson | Chief Executive Officer | 0 companies |
| Mia Karolin Eklund | Liquidator | 0 companies |
| Meg Tivéus Borglin | Board of Directors | 0 companies |
| Johanna Maria Kristina Andlin | Board of Directors | 0 companies |
| Tania Tateossian Persson | Board of Directors | 0 companies |
| Eva Agneta Edberg | Chairman | 0 companies |
| Kent Mikael Nordenstjerna | Chairman | 0 companies |
| Mario Ignazio Clementi | Board of Directors | 0 companies |
| Åsa Margaretha Jilkén | Deputy Board Member | 0 companies |
| Julie Bindslev | Board of Directors | 0 companies |